3results about How to "Easy to refine" patented technology

This invention, entitled "A Low-Loss β-Carotene Microcapsule and Its Preparation Method," belongs to the field of microcapsule preparation technology. The technical problem to be solved is that during high-temperature melting, particulate all-trans β-carotene transforms into a molecular state, but this process generates a large number of cis isomers and results in significant content loss. Furthermore, the particle size and dispersibility of the particulate β-carotene prepared by grinding are still unsatisfactory, leading to low bioavailability and poor application effects. The key point of this technical solution is to prepare high all-trans molecular β-carotene microcapsules through a specific combination of treatments. This reduces content loss and cis-trans isomerization during the transformation of β-carotene from particulate to molecular state, thereby significantly improving the bioavailability of β-carotene microcapsules. Moreover, the preparation process is simple, cost-controllable, and suitable for large-scale industrial production.

This invention discloses a chemical-biological fusion method for cholesterol synthesis. Using plant-derived 21-hydroxy-20-methylpregn-4-en-3-one, also known as bis(2-hydroxy-2-yl)-3-one (BA), as a raw material, cholesterol is synthesized through a four-step reaction involving sulfonation, acetylation, enzymatic hydrolysis and reduction, and Grignard coupling. Addressing the drawbacks of traditional animal-derived cholesterol, which carries unpredictable risks of pathogenic bacteria and viruses, this invention uses plant-derived steroidal raw material BA to synthesize cholesterol. This method not only offers high safety, avoiding the risk of pathogenic bacteria and viral infections, but also utilizes the tandem catalysis of esterase and carbonyl reductase during synthesis, along with coenzyme regeneration, to obtain key intermediates with high stereoselectivity and in a safe and clean manner. This significantly shortens the cholesterol synthesis route, increases efficiency, simplifies operation, minimizes solvent recycling losses, reduces waste, and allows for mild reaction conditions. This method is safe, economical, and suitable for industrial production.

This invention discloses a method for preparing 4N ammonium permanganate from low-concentration rhenium-containing waste acid, which is divided into a crude refining stage and a refining stage. The crude refining stage includes a rhenium precipitation process, a leaching process, a hydrolysis process, an acidification process, an extraction process, a back-extraction process, and a crystallization process. The refining stage includes a crude ammonium permanganate dissolution process, an ion exchange process, an extraction process, a back-extraction process, a crystallization process, and a nitration-recrystallization process, ultimately obtaining ammonium permanganate with a purity of 99.99%. In the crude refining stage, this invention first prepares 4N ammonium permanganate from low-concentration rhenium-containing waste acid. Rhenium is efficiently and selectively enriched in concentrated waste acid to obtain a 1% grade rhenium precipitate. Then, a weak oxidation leaching process is used to remove impurities from the precipitate, followed by calcium hydroxide hydrolysis, acidification, high-efficiency extraction, back-extraction, and crystallization to obtain a crude ammonium perrhenate product with a grade of ≥99%. In the refining stage, the crude ammonium perrhenate is dissolved a second time, and a resin ion exchange, extraction, back-extraction, and crystallization process is used to obtain a refined ammonium perrhenate with a grade of ≥99.9%. Finally, a nitration-recrystallization process is used to remove impurities from the refined ammonium perrhenate to achieve a 4N grade quality.